Grande Enhancement Serums
Allegations: Deceptively marketing products as cosmetics without warning that an ingredient in them may cause serious side effects
Ribak et al v. Grande Cosmetics, LLC
21-cv-7973, C.D. Cal.
(Oct. 2021)
GrandeLASH-MD Lash Enhancing Serum, GrandeBROW Brow Enhancing Serum, and GrandeHAIR Enhancement Serum
Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow eyelashes, causes serious side effects, and is only safe to use under medical supervision
Voluntarily dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
Allegations: Deceptively marketing products as cosmetics without warning that an ingredient in them may cause serious side effects
Allegations: Misleadingly marketing products as safe cosmetics when they are actually drugs that contain an ingredient that poses serious health risks
Verdict comes nine years after TINA.org alerted regulator to supplement’s deceptive claims.
Grab your bag now, before Dina & Mita do
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.